2027 年亚太地区药用辅料市场预测 - COVID-19 影响和按产品(有机化学品、无机化学品和其他产品)进行区域分析;功能性(填料和稀释剂、悬浮剂和粘度剂、涂层剂、粘合剂、防腐剂、乳化剂和其他功能性);制剂类型(口服制剂、外用制剂、肠胃外制剂和其他制剂)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 168    |    Report Code: TIPRE00022801    |    Category: Chemicals and Materials

Asia Pacific Pharmaceutical Excipients Market

亚太地区药用辅料市场预计将从2022年的11.4355亿美元增长到2028年的18.5635亿美元。预计复合年增长率为8.4 % 从 2022 年到 2028 年。

 

利用纳米技术提高辅料能力正在推动增长亚太药用辅料市场的份额

 

纳米递送系统和纳米医学是新兴且快速发展的领域,纳米级材料用于将治疗剂输送到目标部位或作为诊断工具。纳米技术通过针对特定部位和选择性地输送准确的药物,在治疗人类慢性疾病方面提供了多种优势。纳米技术在疾病预防和治疗中的应用为难以输送的活性药物成分的分配创造了广阔的论坛。纳米技术辅助药物输送系统 (NADDS) 的使用增加已显示出许多好处,从提高口服生物利用度到将药物靶向特定组织。 NADDS 在生产和制造方面面临挑战。许多赋形剂用于防止加工过程中聚集并实现纳米级尺寸。纳米赋形剂是在 NADDS 制造过程中有意制造或无意产生的。在 NADDS 的制造过程中,该过程有可能将赋形剂转化为纳米赋形剂。与赋形剂相比,纳米赋形剂具有增强的特性。纳米赋形剂很容易通过生物膜运输。此外,它们很容易被吸收到血液中并输送到目标组织和细胞。纳米赋形剂在循环系统中停留较长时间,并按规定剂量释放混合药物。 NADDS 的高效生产包括对赋形剂的理化性质和功能的详细了解。因此,纳米技术赋形剂将在未来几年见证密集的科学研究,因为它们可以为药品提供独特的功能。纳米技术在纳米辅料开发和药物生产中的使用增加推动了亚太地区药用辅料市场的增长。

 

亚太地区药用辅料市场概况

 

亚太地区是全球增长最快的地区由于发展中国家主要参与者的兴趣日益浓厚,以及越来越多的主要参与者愿意将其药用辅料制造活动外包到低制造和劳动力成本的领域,预计 2021 年全球药用辅料市场将迎来新的发展。中国和印度等国家人口的增长可能会增加该地区对药用辅料的需求。我国已推出500多种药用辅料。据世界卫生组织统计,中国约有400家药用辅料生产商,其中超过23%专门生产药用辅料,其余则专注于化学或食品加工。目前,国外药用辅料龙头企业,如美国卡乐康、德国麦格勒、德国德固赛、法国罗盖特等均已在中国设立合资公司、独资公司或办事处。卡乐康提供薄膜包衣产品,罗盖特制药提供淀粉,Meggle 主要提供药用乳糖和多元醇。中国药用辅料巨头包括三和药用、尔康药业、东宝生物、展望药业、青海明胶、山东聊城阿华药业、曲阜天利等。尽管如此,其市场集中度仍相对较低。

 

亚太地区药用辅料市场收入及2028年预测(美元)百万)

 

 

 

亚太地区药用辅料市场细分

 

亚太地区药用辅料市场分为类型、临床适应症、功能、应用、最终用户和国家。根据类型,亚太地区药用辅料市场分为生物可吸收聚合物和生物可吸收聚合物。脂质和脂质体配方、油脂化学品、糖、纤维素、淀粉、石化产品、植物蛋白和多元醇和环糊精、无机化学品等。 2022年,无机化学品细分市场占据最大市场份额。

 

根据临床适应症,亚太药用辅料市场细分为癌症、代谢、传染病、牙科、眼科、基因治疗等。 2022年,癌症细分市场占据最大市场份额。

 

根据功能,亚太药用辅料市场分为着色剂和;包衣剂、甜味剂和调味剂、悬浮剂和粘度剂、防腐剂控释、抗氧化剂和油、片剂填充剂和稀释剂、粘合剂和压缩辅助工具和造粒剂、乳化剂等。片剂填充剂和稀释剂细分市场在 2022 年占据最大市场份额。

 

根据应用,亚太药用辅料市场细分为肠胃外、口服制剂和制剂片剂、胶囊、液体和预充式注射器、营养保健品和药物中可注射的物理化学赋形剂容器的相互作用非处方药、外用药等。口服制剂和制剂片剂细分市场在 2022 年占据最大市场份额。

 

根据最终用户,亚太药用辅料市场分为生物制药行业、制药行业、动物保健等。制药行业细分市场在 2022 年占据最大市场份额。

 

按国家/地区划分,亚太地区药用辅料市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。 2022 年,中国将主导市场。

 

Archer-Daniels-Midland Co、AshLand Inc、Avantor Inc、BASF SE、Evonik Industries AG、 JRS PHARMA 有限公司Co. KG、MEGGLE GmbH & Co. KG Co KG、Roquette Freres SA、陶氏化学公司和路博润公司是亚太药用辅料市场上的领先公司。



Asia Pacific Pharmaceutical Excipients Strategic Insights

Strategic insights for Asia Pacific Pharmaceutical Excipients involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-pharmaceutical-excipients-market-strategic-framework.webp
Get more information on this report

Asia Pacific Pharmaceutical Excipients Report Scope

Report Attribute Details
Market size in 2022 US$ 1,143.55 Million
Market Size by 2028 US$ 1,856.35 Million
Global CAGR (2022 - 2028) 8.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 有机化学品
  • 无机化学品
  • 其他产品
By 功能性
  • 填充剂和稀释剂
  • 悬浮剂和粘度剂
  • 涂层剂
  • 粘合剂
  • 防腐剂
  • 乳化剂
  • 其他功能性
By 剂型类型
  • 口服剂型
  • 外用剂型
  • 肠外剂型
  • 其他剂型
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Archer-Daniels-Midland Co
  • AshLand Inc
  • Avantor Inc
  • BASF SE
  • Evonik Industries AG
  • JRS PHARMA GmbH & Co. KG
  • MEGGLE GmbH & Co KG
  • Roquette Freres SA
  • The Dow Chemical Co
  • The Lubrizol Corp
  • Get more information on this report

    Asia Pacific Pharmaceutical Excipients Regional Insights

    The regional scope of Asia Pacific Pharmaceutical Excipients refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-pharmaceutical-excipients-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Pharmaceutical Excipients Market

    1. Archer-Daniels-Midland Co
    2. AshLand Inc
    3. Avantor Inc
    4. BASF SE
    5. Evonik Industries AG
    6. JRS PHARMA GmbH & Co. KG
    7. MEGGLE GmbH & Co KG
    8. Roquette Freres SA
    9. The Dow Chemical Co
    10. The Lubrizol Corp
    Frequently Asked Questions
    How big is the Asia Pacific Pharmaceutical Excipients Market?

    The Asia Pacific Pharmaceutical Excipients Market is valued at US$ 1,143.55 Million in 2022, it is projected to reach US$ 1,856.35 Million by 2028.

    What is the CAGR for Asia Pacific Pharmaceutical Excipients Market by (2022 - 2028)?

    As per our report Asia Pacific Pharmaceutical Excipients Market, the market size is valued at US$ 1,143.55 Million in 2022, projecting it to reach US$ 1,856.35 Million by 2028. This translates to a CAGR of approximately 8.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Pharmaceutical Excipients Market report typically cover these key segments-

  • 产品 (有机化学品, 无机化学品, 其他产品)
  • 功能性 (填充剂和稀释剂, 悬浮剂和粘度剂, 涂层剂, 粘合剂, 防腐剂, 乳化剂, 其他功能性)
  • 剂型类型 (口服剂型, 外用剂型, 肠外剂型, 其他剂型)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Pharmaceutical Excipients Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pharmaceutical Excipients Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Pharmaceutical Excipients Market?

    The Asia Pacific Pharmaceutical Excipients Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Archer-Daniels-Midland Co
  • AshLand Inc
  • Avantor Inc
  • BASF SE
  • Evonik Industries AG
  • JRS PHARMA GmbH & Co. KG
  • MEGGLE GmbH & Co KG
  • Roquette Freres SA
  • The Dow Chemical Co
  • The Lubrizol Corp
  • Who should buy this report?

    The Asia Pacific Pharmaceutical Excipients Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Pharmaceutical Excipients Market value chain can benefit from the information contained in a comprehensive market report.